scorecardresearch
Sunday, July 27, 2025
TopicBioNTech

Topic: BioNTech

Pfizer-BioNTech vaccine could help end Covid pandemic, Israel study shows

Two doses prevented 94% of Covid-19 cases in 596,618 people vaccinated between 20 Dec and 1 Feb, teams from Clalit Research Institute and Harvard University reported in a study.

Pfizer-BioNTech vaccine could foil the UK Covid strain, new study shows

The results published Wednesday showed that antibodies in the blood of people who had been vaccinated were able to neutralize a version of the mutant virus that was created in the lab.

Pfizer, BioNTech boost their Covid vaccine goal for 2021 to 2 billion doses

More than 50% boost from previous 2021 target of 1.3 billion doses, the increase incorporates a label change that will allow doctors to extract 6 doses instead of 5 from each vaccine vial.

Dubai to offer free Pfizer-BioNTech Covid vaccine shots from Wednesday

Dubai locked down the city for about a month earlier this year to halt the spread of the virus. The UAE diagnosed over 195,000 people with Covid since the start of the outbreak.

Vaccine can be reset to combat new Covid strain in just 6 weeks, BioNTech says

BioNTech SE Chief Executive Officer said if the current shot fails to be adequately protective, they could tweak it by updating small bits of genetic information called messenger RNA.

BioNTech confident vaccine effective against new Covid strain

BioNTech's chief executive officer said lab tests of the vaccine’s performance have been done against 20 mutant versions; the same tests will now be run against the new UK version.

Pfizer Covid shot is highly effective, has no safety concerns, US FDA staff report says

The report offers a first look at the US review of the vaccine ahead of a public meeting Thursday of outside advisers to the agency.

BioNTech founder Ugur Sahin joins world’s 500 richest after UK approves Covid vaccine

BioNTech’s shares have jumped almost 8% this week and are up more than 250% for the year. Sahin is now the 493rd-richest person on the planet with a net worth of $5.1 billion.

Pfizer, BioNTech seek regulatory clearance from EU for Covid vaccine

BioNTech Chief Financial Officer said the company can start shipping the first doses 'within hours' after regulatory clearance.

With Pfizer winning race to prove efficacy, what happens to other Covid vaccines

It’s an abundance that never happened in the history of vaccines. Balancing urgency with research ethics won’t be easy. But so much rides on getting it right.

On Camera

Maharashtra’s language war reaches West Bengal. Actor Prosenjit Chatterjee is the first victim

While the language war in other states is targeting those who can't speak the local language, in Bengal, even those whose mother tongue is Bengali have to constantly prove their Bengali-ness.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

DRDO successfully tests latest version of UAV-launched precision missile, ULPGM-V3

Capable of being fired in plain and high-altitude areas, it has day-and-night capability and two-way data link to support post-launch target, aim-point update.

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.